Recent Lectures and Presentations
2004: Featured Debate between Dr. Cohen and Dr. Robert Temple, M.D., Director, Office of Medical Policy and Office of Drug Evaluation I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration. Held at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics on March 26 in Miami, Dr. Cohen spoke on: “Causes and Solutions for Problems with Cholesterol-Lowering, Antidepressant, Antihypertensive, Anti-inflammatory, and Other Major Drugs: Practical Changes in Drug Company Research, FDA Regulation, and Doctors Methods.” This was the fourth Cohen-Temple debate and was organized by chairperson Peter Honig, M.D., Senior Vice President of Worldwide Regulatory Affairs and Problem Safety, \ Merck Research Laboratories. Dr. Honig was previously the director of Medwatch at the FDA.
2003: Featured Speaker, National Conference of the American College for the Advancement of Medicine (ACAM), November 24, Las Vegas. “Mainstream Vs. Alternative Medicine: Why We Don’t Have a Rational Integrative Medical System and How to Achieve This.” ACAM is America’s largest organization of integrative and alternative physicians.
2003: Featured Speaker, Drug Information Association (DIA) Conference, San Antonio, June 15. “Preventing Medication Side Effects: Improvements in Drug Industry Research and FDA Review Can Improve Patients’ Trust and Adherence to Treatment.” Third Debate with Robert Temple, M.D., Director, Office of Medical Policy and Office of Drug Evaluation I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
2003: Keynote Speaker, Direct-To-Consumer Conference for 450 pharmaceutical industry executives, March 26, 2003. President Patrick Kelly; CEO of GlaxoWellcome; Ralph Nader. “Improving Patients’ Trust, Satisfaction, and Adherence to Treatment by Preventing Medication Side Effects.” Other keynote speakers: Pfizer U.S.
2003: Featured Speaker, Thomas Jefferson School of Law, San Diego, February 13, 2003. “Medications, Side Effects, and Informed Consent: Deeper Problems Than Attorneys and Patients Realize.”
2003: Featured Speaker, Kaiser Permanente Positive Choice Wellness Center. “Scientifically-Proven Natural Alternatives for Medical Therapy.”
2002: Keynote Speaker, Annual Science Day, Clinical Pharmacology Division, U.S. Food and Drug Administration, November 1, 2002. “Dose Optimization and Preventing Adverse Events: A Clinical Physician’s Perspective on Improving Drug Safety.”
2002: Leadoff Speaker, National Conference of the American College for the Advancement of Medicine (ACAM), May
2002. “Why Medication Side Effects Occur and How to Prevent Them. The Information the Drug Companies and FDA Don’t Give You.” ACAM is America’s largest organization of alternative physicians (400 in attendance).
2002: Congress of California Seniors, San Diego, May 2002. “Avoiding Medication Side Effects in Seniors: Preventable Problems in the Drug Industry and FDA.” Other featured speakers: Governor Gray Davis, Lieutenant Governor Cruz Bustamante.
2001: National Public Radio, “Morning Edition with Bob Edwards,” Oct. 30. “Preventing and Recognizing Adverse Effects with Cipro. Are Other Antibiotics Better Choices?“